Picture of Tauriga Sciences logo

TAUG Tauriga Sciences Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual income statement for Tauriga Sciences, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

2017
March 31st
R2018
March 31st
2019
March 31st
C2020
March 31st
2021
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue000.0570.2340.285
Cost of Revenue
Gross Profit000.020.0540.123
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses1.45-0.471.192.153.99
Operating Profit-1.450.47-1.13-1.92-3.7
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes-2.270.003-1.1-3.03-3.63
Net Income After Taxes-2.270.003-1.1-3.03-3.63
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income-2.27-0.036-1.1-3.03-3.63
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-2.27-0.307-1.1-3.03-3.63
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.124-0.078-0.019-0.039-0.017